Total trials
304
Active
55
Phase 3
15
Total enrollment
245,455
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Normal Saline | — | — | — | 4 | |||
| iron sulfate | — | — | — | — | — | 1 | |
| Gabapentin 600mg | — | — | — | — | — | 1 | |
| Aspirin 325Mg Tab, Aspirin 81Mg Tab | — | — | — | — | — | 1 | |
| Magnesium sulfate | — | — | — | — | — | 1 | |
| Toothpaste | — | — | — | — | — | 2 | |
| Conventional Toothpaste | — | — | — | — | — | 2 | |
| Oral Nifedipine | — | — | — | — | — | 1 | |
| Oral Labetalol | — | — | — | — | — | 1 | |
| Povidone-Iodine | — | — | — | — | — | 1 | |
| Gemcitabine 1000 mg | — | — | — | — | — | 1 | |
| nab-paclitaxel | — | — | — | — | — | 1 | |
| Lidocaine | — | — | — | — | 3 | ||
| Morphine 0,1 mg/kg | — | — | — | — | — | 1 |
Next readouts
- 2026-09
- 2026-10
- 2026-12
- 2026-12
- 2026-12
- 2026-12
- 2027-03
- 2027-05
- 2027-06
- 2027-12
Top conditions
- Obesity9
- Inflammation8
- Autism Spectrum Disorder6
- Pain5
- Immune Response5
- Stroke4
- Healthy4
- Type 2 Diabetes4
Frequently asked questions about Loma Linda University
- How many clinical trials does Loma Linda University have on ClinicalTrials.gov?
- Loma Linda University is listed as the lead sponsor on 304 clinical trials in ClinicalTrials.gov, 55 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Loma Linda University's trials are in Phase 3?
- 15 of Loma Linda University's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Loma Linda University focus on?
- Loma Linda University's most-studied conditions on ClinicalTrials.gov are Obesity, Inflammation, Autism Spectrum Disorder, Pain, Immune Response.
- When are Loma Linda University's next clinical trial readouts?
- Loma Linda University has 10 upcoming primary-completion readouts tracked here; the soonest is “Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer”, expected around 2026-09.